Crossref
Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis
The Medical Letter on Drugs and Therapeutics · 02.03.2026 · 68 (1749) · e43-e44
DOI: 10.58347/tml.2026.1749e ↗Kurz gefasst
Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, online erschienen am 02.03.2026.
Abstract (Originalsprache)
Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis
Schlagwörter
Stichwörter der Autor:innen
AdbryCibinqoDupixentEbglyssNemluvioRinvoqabrocitinibatopic dermatitisdosagedupilumabefficacylebrikizumabnemolizumabtralokinumabupadacitinib
Zitieren
APA
(2026). Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis. The Medical Letter on Drugs and Therapeutics, 68(1749), e43-e44. https://doi.org/10.58347/tml.2026.1749e
Vancouver
Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis. The Medical Letter on Drugs and Therapeutics. 2026;68(1749):e43-e44. doi:10.58347/tml.2026.1749e
BibTeX
@article{euvimed2026,
title = {Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis},
journal = {The Medical Letter on Drugs and Therapeutics},
year = {2026},
volume = {68},
number = {1749},
pages = {e43--e44},
doi = {10.58347/tml.2026.1749e}
}
EUVIMED